CD160 and neoplasm: Further, TNFRSF25, PDCD1LG2, CD276, CD80, HAVCR2, LAIR1, CD160, TNFRSF14, ADORA2A, and CD48 were significantly associated with BACE1-AS expression in more than half of the tumor types.